RxSight, Inc.

Annual Trend FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $14.7m $22.6m $49.0m $89.1m $139.9m $134.5m
Cost of Revenue $13.0m $18.1m $27.7m $35.3m $41.0m $31.5m
Reconciled Cost Of Revenue $13.0m $18.1m $27.7m $35.3m $41.0m $31.5m
Gross Profit $1.7m $4.5m $21.3m $53.8m $98.9m $103.0m
Research And Development $21.9m $24.5m $26.0m $29.1m $34.4m $38.5m
Operating Expenses $37.1m $57.3m $84.6m $103.8m $135.8m $151.2m
Operating Income (Loss) ($35.4m) ($52.8m) ($63.3m) ($50.1m) ($36.9m) ($48.2m)
Additional Financial Items
Income (Loss) from Continuing Operations before Income Taxes, Domestic $27.6m ($48.7m) ($66.8m) ($48.6m) ($27.4m) ($38.9m)
Interest and Other Income $54k $1.5m $6.6m $9.5m $9.3m
Diluted EPS $0.91 ($3.57) ($2.41) ($1.41) ($0.71) ($0.95)
Diluted NI Availto Com Stockholders $27.6m ($48.7m) ($66.8m) ($48.6m) ($27.5m) ($38.9m)
Interest Income $54k $1.5m $6.6m $9.5m $9.3m
Interest Income Non Operating $54k $1.5m $6.6m $9.5m $9.3m
Net Income From Continuing And Discontinued Operation $27.6m ($48.7m) ($66.8m) ($48.6m) ($27.5m) ($38.9m)
Net Income From Continuing Operation Net Minority Interest $27.6m ($48.7m) ($66.8m) ($48.6m) ($27.5m) ($38.9m)
Net Interest Income ($3.4m) $3.3m $9.5m $9.3m
Normalized EBITDA ($57.8m) ($39.4m) ($23.8m) ($35.6m)
Normalized Income ($66.8m) ($46.8m) ($27.5m) ($38.9m)
Reconciled Depreciation $4.0m $4.1m $3.6m $3.3m
Selling General And Administration $15.2m $32.8m $58.7m $74.8m $101.4m $112.7m
Special Income Charges $0 ($1.8m) $0 $0
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Provision $57k $8k $9k $20k $50k $66k
Tax Rate For Calcs $0 $0 $0 $0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $27.6m ($48.7m) ($66.7m) ($48.6m) ($27.4m) ($38.9m)
Total Unusual Items $0 ($1.8m) $0 $0
Total Unusual Items Excluding Goodwill $0 ($1.8m) $0 $0
Pre-Tax Income $27.6m ($48.7m) ($66.7m) ($48.6m) ($27.4m) ($38.9m)
Net Income Continuous Operations $27.6m ($48.7m) ($66.8m) ($48.6m) ($27.5m) ($38.9m)
Net Income (Loss) Attributable to Parent $27.6m ($48.7m) ($66.8m) ($48.6m) ($27.5m) ($38.9m)
Net Income (Loss) Available to Common Stockholders, Basic $3.4m ($48.7m) ($66.8m) ($48.6m) ($27.5m) ($38.9m)
Net Income Including Noncontrolling Interests $27.6m ($48.7m) ($66.8m) ($48.6m) ($27.5m) ($38.9m)
Earnings Per Share, Basic $0.91 ($3.57) ($2.41) ($1.41) ($0.71) ($0.95)
Earnings Per Share, Diluted $0.15 ($3.57) ($2.41) ($1.41) ($0.71) ($0.95)
Weighted Average Number of Shares Outstanding, Basic 3.7m 13.6m 27.7m 34.5m 38.9m 40.9m
Basic Average Shares 3.7m 13.6m $27.7m $34.5m $38.9m $40.9m
Diluted Average Shares 3.7m 13.6m $27.7m $34.5m $38.9m $40.9m
Weighted Average Number of Shares Outstanding, Diluted 5.5m 13.6m 27.7m 34.5m 38.9m 40.9m
Research and Development Expense $21.9m $24.5m $26.0m $29.1m $34.4m $38.5m
Selling, General and Administrative Expense $15.2m $32.8m $58.7m $74.8m $101.4m $112.7m
Cost, Depreciation and Amortization $3.9m $4.0m $3.9m $4.1m $3.6m $3.3m
Interest Expense $510k $3.7m $4.9m $3.3m $21k $19k
Current Income Tax Expense (Benefit) $57k $8k $9k $20k $50k $66k
Interest Expense Non Operating $510k $3.7m $4.9m $3.3m $21k $19k
Net Non Operating Interest Income Expense ($3.4m) $3.3m $9.5m $9.3m
Operating Expense $37.1m $57.3m $84.6m $103.8m $135.8m $151.2m
Other Income Expense $7.7m ($1.8m)
Income Tax Expense (Benefit) $57k $8k $9k $20k $50k $66k
Total Expenses $112.3m $139.2m $176.8m $182.7m